.STUDY FEATURE.06 August 2024.
A large randomized measured test along with cisgender females highlights the difficulties of faithfulness to a regular oral preexposure prevention routine and shows that twice-yearly shot of lenacapavir can maintain successful HIV deterrence levels over 6 months.